HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Joseph Rausch Selected Research
Joseph Rausch Research Topics
Disease
2
Autism Spectrum Disorder
12/2022 - 11/2017
2
Autistic Disorder (Autism)
01/2022 - 01/2018
2
Cystic Fibrosis (Mucoviscidosis)
07/2019 - 06/2016
2
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2018 - 08/2011
2
Epilepsy (Aura)
06/2014 - 07/2013
2
Snoring
09/2012 - 02/2012
1
Neoplasms (Cancer)
06/2021
1
Exocrine Pancreatic Insufficiency
07/2019
1
Poisoning
01/2019
1
Asphyxia (Suffocation)
01/2019
1
Gestational Diabetes (Gestational Diabetes Mellitus)
07/2017
1
Pediatric Crohn's disease
01/2016
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2014
1
Birth Weight (Birth Weights)
09/2012
1
Night Terrors (Sleep Terror)
02/2012
1
Psychomotor Agitation (Akathisia)
02/2012
Drug/Important Bio-Agent (IBA)
3
Fatty Acids (Saturated Fatty Acids)
IBA
12/2022 - 01/2018
2
Anticonvulsants (Antiepileptic Drugs)
IBA
06/2014 - 07/2013
1
Lipids
IBA
07/2019
1
insulin receptor-related receptor (IRR)
IBA
01/2019
1
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
01/2018
1
Docosahexaenoic Acids
IBA
01/2018
1
Indicators and Reagents (Reagents)
IBA
11/2017
1
Sugars
IBA
07/2017
1
imidazole mustard (BIC)
IBA
06/2016
1
Minerals
IBA
01/2016
1
Blood Glucose (Blood Sugar)
IBA
10/2014
1
Smoke
IBA
09/2012
1
Cotinine
IBA
09/2012
1
N-(4-aminophenethyl)spiroperidol (NAPS)
IBA
02/2012
1
Pemetrexed (MTA)
FDA Link
08/2011
Therapy/Procedure
1
Therapeutics
06/2021
1
Aftercare (After-Treatment)
09/2012
1
Combined Modality Therapy
08/2011